4.8 Article

A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma

Journal

ONCOGENE
Volume 38, Issue 10, Pages 1611-1624

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41388-018-0548-x

Keywords

-

Funding

  1. Science Fund for Creative Research Groups of the National Natural Science Foundation of China [81521004]
  2. State Key Program of National Natural Science of China [31530047]
  3. National Key Research and Development Program of China [2017YFC0907905]
  4. Young Scientists Fund of the National Natural Science Foundation of China [81703295, 81702266]
  5. National Key Basic Research Program Grant [2015CB943003]
  6. Ten Thousand Talent Program
  7. Natural Science Foundation of Jiangsu Province [BK20160046]
  8. Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)
  9. Top-notch Academic Programs Project of Jiangsu Higher Education Institutions [PPZY2015A067]
  10. Jiangsu Specially-Appointed Professor project

Ask authors/readers for more resources

Our previous work found cancer-testis (CT) genes as a new source of epi-driver candidates of cancer. LIN28B was a CT gene, but the driver ability and the activation mechanism in lung adenocarcinoma (LUAD) remain unclear. We observed that LIN28B expression was restricted in testis. It was re-activated in LUAD patients without known genomic alterations in oncogenes and was related to poorer survival. In vitro and In vivo experiments confirmed that the activation of LIN28B could promote the proliferation and metastasis of LUAD cells and can influence cell cycle, DNA damage repair, and genome instability. In addition to the known let-7-LIN28B regulation loop, our results further revealed a let-7-independent Cis-regulator of LIN28B: LIN28B-ASI. LIN28B-ASI is a CT long non-coding RNA (CT-lncRNA). It altered the messenger RNA stability of LIN28B by directly interacting with another CT protein IGF2BP1 but not with LIN28B and constituted a novel regulation network. In sum, we identify that LIN28B is an epi-driver of LUAD and clarify a new lncRNA-activated mechanism of LIN28B, which provide new candidate targets for precise anticancer therapy in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available